Market Currents
Novartis (NVS) is due to appear before India's Supreme Court on Wednesday in an attempt to gain...
-
Monday, August 20, 2012, 4:29 AM ETNovartis (NVS) is due to appear before India's Supreme Court on Wednesday in an attempt to gain patent protection for its leading cancer-drug Glivec, which the Indian government declined to provide. The case comes as India, although suffering from a slowing economy and high inflation, becomes increasingly unpredictable and unfriendly for foreign companies.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
